Non-Alcoholic Fatty Liver Disease Trial, Recruiting NCT04525833 Sponsor: Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation Condition: Non-Alcoholic Fatty Liver Disease
Back to Non Alcoholic Fatty Liver Disease

Non-Alcoholic Fatty Liver Disease Trial, Recruiting

NCT04525833
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have visited the gastroenterology (digestive health) clinics at the Tzu Chi Hospitals, Buddhist Tzu Chi Medical Foundation

Who may not be able to join:

  • People who are younger than 18 years old or older than 99 years old

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ching-Sheng Hsu, Ph.D, Liver Diseases Research Center, Taipei Tzu Chi Hospital

Phone: 886-979239381

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Registry
ClinicalTrials.gov
Start date
1 January 2020
Est. completion
31 December 2025

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

The incidence of a new diagnosis of hepatocellular carcinoma (HCC); The incidence of a new diagnosis of any event of liver cirrhosis complications

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov